Search research articles
Contact Us
Filters
Showing results (121-130 of 137) with videos related to
Page
of 14
Sort By:
Pediatric Blood & Cancer
|
December 31, 2016
A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumors
Oren J Becher, Stephen W Gilheeney, Yasmin Khakoo, et al.
Journal of Pediatric Surgery
|
October 6, 2010
Preliminary results of a phase I trial of prophylactic ethanol-lock administration to prevent mediport catheter-related bloodstream infections
Mark L Kayton, Edward G Garmey, Nicole M Ishill, et al.
Plos Genetics
|
December 21, 2016
Enrichment of Targetable Mutations in the Relapsed Neuroblastoma Genome
Olivia M Padovan-Merhar, Pichai Raman, Irina Ostrovnaya, et al.
Journal for Immunotherapy of Cancer
|
March 22, 2024
Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells
Maxim Yankelevich, Archana Thakur, Shakeel Modak, et al.
Oncoimmunology
|
September 18, 2018
Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study
Shakeel Modak, Jean-Benoit Le Luduec, Irene Y Cheung, et al.
Pediatrics
|
August 2, 2019
Local Anesthesia With General Anesthesia for Pediatric Bone Marrow Procedures
Sara Zarnegar-Lumley, Katharine R Lange, Melissa D Mathias, et al.
Pediatric Blood & Cancer
|
July 5, 2024
Ovarian function in female survivors of high-risk neuroblastoma
Lauren Jimenez-Kurlander, Amelia DeRosa, Caroline E Kostrzewa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2017
A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors
Birgit Geoerger, Franck Bourdeaut, Steven G DuBois, et al.
Plos One
|
June 6, 2017
A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors
Oren J Becher, Nathan E Millard, Shakeel Modak, et al.
Journal of Hematology & Oncology
|
November 12, 2022
Phase 1 study of intraventricular <sup>131</sup>I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies
Kim Kramer, Neeta Pandit-Taskar, Brian H Kushner, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 137) with videos related to
Sort By:
Page
of 14
Pediatric Blood & Cancer
|
December 31, 2016
A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumors
Oren J Becher, Stephen W Gilheeney, Yasmin Khakoo, et al.
Journal of Pediatric Surgery
|
October 6, 2010
Preliminary results of a phase I trial of prophylactic ethanol-lock administration to prevent mediport catheter-related bloodstream infections
Mark L Kayton, Edward G Garmey, Nicole M Ishill, et al.
Plos Genetics
|
December 21, 2016
Enrichment of Targetable Mutations in the Relapsed Neuroblastoma Genome
Olivia M Padovan-Merhar, Pichai Raman, Irina Ostrovnaya, et al.
Journal for Immunotherapy of Cancer
|
March 22, 2024
Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells
Maxim Yankelevich, Archana Thakur, Shakeel Modak, et al.
Oncoimmunology
|
September 18, 2018
Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study
Shakeel Modak, Jean-Benoit Le Luduec, Irene Y Cheung, et al.
Pediatrics
|
August 2, 2019
Local Anesthesia With General Anesthesia for Pediatric Bone Marrow Procedures
Sara Zarnegar-Lumley, Katharine R Lange, Melissa D Mathias, et al.
Pediatric Blood & Cancer
|
July 5, 2024
Ovarian function in female survivors of high-risk neuroblastoma
Lauren Jimenez-Kurlander, Amelia DeRosa, Caroline E Kostrzewa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2017
A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors
Birgit Geoerger, Franck Bourdeaut, Steven G DuBois, et al.
Plos One
|
June 6, 2017
A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors
Oren J Becher, Nathan E Millard, Shakeel Modak, et al.
Journal of Hematology & Oncology
|
November 12, 2022
Phase 1 study of intraventricular <sup>131</sup>I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies
Kim Kramer, Neeta Pandit-Taskar, Brian H Kushner, et al.
Page
of 14